SPSTF yields 3.71% · JNJ yields 2.14%● Live data
📍 JNJ pulled ahead of the other in Year 6
Combined, SPSTF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SPSTF + JNJ for your $10,000?
Singapore Post Limited, together with its subsidiaries, engages in post and parcel, eCommerce logistics, and property businesses in Singapore, Japan, Europe, New Zealand, Hong Kong, Australia, and internationally. It operates through Post and Parcel, Logistics, and Property segments. The Post and Parcel segment offers services for collecting, sorting, transporting, and distributing domestic and international mail, as well as sells philatelic products. This segment also provides agency services, financial services, and parcel deliveries. The Logistics segment offers freight forwarding and eCommerce logistics solutions, which includes front-end related eCommerce solutions, warehousing, fulfilment, delivery, and other value-added services. The Property segment provides commercial property rental, and self-storage services. The company is also involved in the online sale of products; and provision of management and consultancy services to related entities, as well as integrated supply chain and distribution services, and logistics consulting services. In addition, it provides customs brokerage and freight forwarding services; and freight collections transshipments services. Additionally, the company provides online shopping platforms and services. The company was founded in 1819 and is headquartered in Singapore.
Full SPSTF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.